Artículos de revistas sobre el tema "Distinct entity"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Distinct entity.

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Distinct entity".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Husein El Ahmed, Husein y Carmen Dulanto-Campos. "A distinct entity". American Journal of Obstetrics and Gynecology 208, n.º 1 (enero de 2013): 89.e1–89.e2. http://dx.doi.org/10.1016/j.ajog.2012.10.864.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Gleich, Tobias, Elena Chiticariu, Marcel Huber y Daniel Hohl. "Keratoacanthoma: a distinct entity?" Experimental Dermatology 25, n.º 2 (4 de diciembre de 2015): 85–91. http://dx.doi.org/10.1111/exd.12880.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Grof, Paul. "Melancholia: A Distinct Entity?" Canadian Journal of Psychiatry 58, n.º 4 (abril de 2013): 181–82. http://dx.doi.org/10.1177/070674371305800401.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

H. Khaparde, Sadhana, Sanjay D. Deshmukh, Baba B. Shinde, Prajacta Rane y Shaleen Lamba. "Sialadenoma Papilliferum of Buccal Mucosa : A Rare and Distinct Entity". Indian Journal of Pathology: Research and Practice 5, n.º 2 (2016): 219–21. http://dx.doi.org/10.21088/ijprp.2278.148x.5216.28.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Agarwal, Amar, Priya Narang y DhivyaAshok Kumar. "Predescemetocele: A distinct clinical entity". Indian Journal of Ophthalmology 65, n.º 11 (2017): 1224. http://dx.doi.org/10.4103/ijo.ijo_492_17.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Bomback, Andrew S. y Glen S. Markowitz. "Lupus Podocytopathy: A Distinct Entity". Clinical Journal of the American Society of Nephrology 11, n.º 4 (16 de marzo de 2016): 547–48. http://dx.doi.org/10.2215/cjn.01880216.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Joshi, Rajiv y Yatin Jadhav. "Penoscrotal porokeratosis: A distinct entity". Indian Dermatology Online Journal 6, n.º 5 (2015): 339. http://dx.doi.org/10.4103/2229-5178.164487.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Levine, Jimmy, Michael H. Schmidt, Morton I. Burrell y Michael S. Hopkins. "Acute Jejunoileitis. A Distinct Entity?" Journal of Clinical Gastroenterology 14, n.º 1 (enero de 1992): 47–51. http://dx.doi.org/10.1097/00004836-199201000-00012.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Walters, Glenn D. "Dementia: Continuum or distinct entity?" Psychology and Aging 25, n.º 3 (2010): 534–44. http://dx.doi.org/10.1037/a0018167.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

McMillan, Marcia J. y R. O. Pihl. "Premenstrual depression: A distinct entity." Journal of Abnormal Psychology 96, n.º 2 (1987): 149–54. http://dx.doi.org/10.1037/0021-843x.96.2.149.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Dixon, M. F., H. J. O'Connor, A. T. Axon, R. F. King y D. Johnston. "Reflux gastritis: distinct histopathological entity?" Journal of Clinical Pathology 39, n.º 5 (1 de mayo de 1986): 524–30. http://dx.doi.org/10.1136/jcp.39.5.524.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Pranteda, Bottoni, De Simone, Calvieri y Grieco. "Bullous keloid: a distinct entity?" British Journal of Dermatology 141, n.º 2 (agosto de 1999): 375–77. http://dx.doi.org/10.1046/j.1365-2133.1999.03013.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Yazıcı, Olcay. "Unipolar mania: A distinct entity?" Journal of Affective Disorders 152-154 (enero de 2014): 52–56. http://dx.doi.org/10.1016/j.jad.2013.10.005.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Amarapurkar, Anjali D., Deepak Amarapurkar, Mehul Choksi, Nirav Bhatt y Pooja Amarapurkar. "Portal hypertensive polyps: distinct entity". Indian Journal of Gastroenterology 32, n.º 3 (20 de marzo de 2013): 195–99. http://dx.doi.org/10.1007/s12664-013-0324-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Ammann, Roland A., Jack Plaschkes y Kurt Leibundgut. "Congenital hepatoblastoma: A distinct entity?" Medical and Pediatric Oncology 32, n.º 6 (junio de 1999): 466–68. http://dx.doi.org/10.1002/(sici)1096-911x(199906)32:6<466::aid-mpo20>3.0.co;2-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Korelitz, Burton I. y Jeffrey Aronoff. "Crohnʼs proctitis: A distinct entity". Inflammatory Bowel Diseases 16, n.º 5 (mayo de 2010): 721–22. http://dx.doi.org/10.1002/ibd.21089.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Hennekam, R. C. M. "LADD syndrome: a distinct entity?" European Journal of Pediatrics 146, n.º 1 (enero de 1987): 94–95. http://dx.doi.org/10.1007/bf00647303.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

LEVINSON, JOSEPH E. "Eosinophilic Fasciitis: A Distinct Entity?" Archives of Pediatrics & Adolescent Medicine 139, n.º 1 (1 de enero de 1985): 8. http://dx.doi.org/10.1001/archpedi.1985.02140030010001.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Garg, RavindraKumar, GyanPrakash Singh, Rajiv Garg, Neeraj Kumar y Anit Parihar. "Severe COVID-19: A distinct entity". Journal of Family Medicine and Primary Care 10, n.º 1 (2021): 84. http://dx.doi.org/10.4103/jfmpc.jfmpc_1600_20.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Pawar, Vipul Mohan. "Verruciform Xanthoma-Histopathologically: A Distinct Entity". Journal of Contemporary Dentistry 4, n.º 3 (2014): 181–84. http://dx.doi.org/10.5005/jp-journals-10031-1093.

Texto completo
Resumen
ABSTRACT Verruciform xanthoma (VX) is an uncommon benign mucocutaneous lesion of unknown etiology. It is essential to diagnose this lesion as a varied entity of utmost importance as clinically their appearance could range from a simple leukoplakia or papilloma to as grave as squamous cell carcinoma SCC. Although this lesion is of multifactorial pathogenesis, a viral etiology like human papilloma virus (HPV) has been suggested in some cases. This rare, harmless lesion usually presents as a sessile or pedunculated, pale yellowish-to-red, papillary, granular or verrucous mucosal growth. Histopathologically, VX is characterized by the presence of parakeratinzed epithelium showing papillary or verrucous growth with thin rete ridges and connective tissue papillae extending up to the surface. The papillae characteristically consist of foam cells, also called xanthoma cells. We report two cases of VX of varied clinical appearance but very similar and characteristic histopathological presentation to be diagnosed as VX. The clinical diagnosis, though may be challenging; the histopathological features are diagnostic and well-defined. It is also noteworthy that in an improper biopsy, xanthoma cells may be scanty and their presence can be missed, especially if one is unfamiliar with the existence of this lesion. How to cite this article Pawar VM, Patel S, Pathak J, Swain N. Verruciform Xanthoma-Histopathologically: A Distinct Entity. J Contemp Dent 2014;4(3):181-184.
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Ray, Katrina. "Eosinophilic colitis — a distinct clinical entity?" Nature Reviews Gastroenterology & Hepatology 19, n.º 3 (1 de febrero de 2022): 148. http://dx.doi.org/10.1038/s41575-022-00583-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Kansal, NaveenKumar, C. Divyalakshmi y Aditi Dhanta. "Lichenoid psoriasis: A distinct morphological entity". Clinical Dermatology Review 4, n.º 1 (2020): 67. http://dx.doi.org/10.4103/cdr.cdr_15_19.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Morris, Gabrielle F., Katrina Murphy, Lucy B. Rorke y Hector E. James. "Spinal hamartomas: a distinct clinical entity". Journal of Neurosurgery 88, n.º 6 (junio de 1998): 954–61. http://dx.doi.org/10.3171/jns.1998.88.6.0954.

Texto completo
Resumen
Object. Congenital spinal hamartomas are defined as tumors of well-differentiated mature elements situated in an abnormal location. In this report, the authors document the clinical and pathological features of spinal hamartomas in 10 patients. Methods. Ten patients presented with midline dorsal malformations at birth, initially diagnosed as teratomas or myelomeningoceles. The locations of the masses were variable: two were located in the thoracic region, four at the thoracolumbar junction, two in the lumbar region, one at the lumbosacral junction, and one in the sacral region. The results of the neurological examination were normal in nine patients. All but one mass had intact skin and seven had palpable bone components. Neuroimaging studies revealed widening of the spinal canal, heterotopic bone located dorsally in some patients, and varying degrees of involvement of the intraspinal contents. During surgery, six patients were found to have involvement of the spinal cord or cauda equina. The pathological characteristics of the masses included three or more of the following: bone, cartilage, synovial membrane, urinary tract tissue, cyst wall, yellow or brown fat, and nerves. The well-differentiated cellular elements, which formed mature structures, along with the absence of primitive cellular components and neoplastic characteristics are more consistent with a diagnosis of hamartoma than teratoma. Conclusions. In this series, the authors describe a lesion that is overt on physical examination, yet can have occult spinal canal involvement. Complete neurosurgical evaluation is essential to provide appropriate treatment and prognosis.
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Wasserfallen, Jean-Blaise, Marie-Denise Schaller, Francois Feihl y Claude H. Perret. "Sudden Asphyxic Asthma: A Distinct Entity?" American Review of Respiratory Disease 142, n.º 1 (julio de 1990): 108–11. http://dx.doi.org/10.1164/ajrccm/142.1.108.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Strong, Russell W. "DIEULAFOY'S DISEASE-A DISTINCT CLINICAL ENTITY". Australian and New Zealand Journal of Surgery 54, n.º 4 (21 de enero de 2008): 337–39. http://dx.doi.org/10.1111/j.1445-2197.1984.tb05329.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Sabatelli, M., F. Madia, L. De Armas y P. Tonali. "PURE MOTOR CIDP. A DISTINCT ENTITY?" Journal of the Peripheral Nervous System 5, n.º 1 (marzo de 2000): 49. http://dx.doi.org/10.1046/j.1529-8027.2000.00513-52.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

FLETCHER, C. D. M., S. E. DAVIES y P. H. MCKEE. "Cellular schwannoma: a distinct pseudosarcomatous entity". Histopathology 11, n.º 1 (3 de abril de 2007): 21–35. http://dx.doi.org/10.1111/j.1365-2559.1987.tb02606.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Gertz, Morie A., Francis K. Buadi, Suzanne R. Hayman, David Dingli, Angela Dispenzieri, Philip R. Greipp, Shaji K. Kumar et al. "Immunoglobulin D amyloidosis: a distinct entity". Blood 119, n.º 1 (5 de enero de 2012): 44–48. http://dx.doi.org/10.1182/blood-2011-06-358895.

Texto completo
Resumen
Abstract IgD monoclonal gammopathies are uncommon. They are seen rarely as a monoclonal gammopathy of undetermined significance and are present in 1%-2% of patients with multiple myeloma. In light-chain amyloidosis, IgD monoclonal proteins are found in ap-proximately 1% of patients. When an IgD monoclonal protein is found, amyloidosis is often omitted from the differential diagnosis. In the present study, we reviewed the natural history of IgD-associated amyloidosis among 53 patients seen over 41 years. The distribution of clinical syndromes suggests that these patients have a lower frequency of renal and cardiac involvement. The overall survival of these patients does not appear to be different from that of patients who have light-chain amyloidosis associated with another monoclonal protein.
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

van der Meijden, Willem I. y Patricia C. Ewing. "Papular Colpitis: A Distinct Clinical Entity?" Journal of Lower Genital Tract Disease 15, n.º 1 (enero de 2011): 60–65. http://dx.doi.org/10.1097/lgt.0b013e3181dc2f6a.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Amarapurakar, Deepak, Anjali D. Amarapurkar, Nirav Bhatt, Mehul J. Choksi y Pooja Amarapurkar. "Su1959 Portal Hypertensive Polyps: Distinct Entity". Gastroenterology 142, n.º 5 (mayo de 2012): S—546. http://dx.doi.org/10.1016/s0016-5085(12)62098-8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Oliver, G. Fergus y R. K. Winkelmann. "Unilesional mycosis fungoides: A distinct entity". Journal of the American Academy of Dermatology 20, n.º 1 (enero de 1989): 63–70. http://dx.doi.org/10.1016/s0190-9622(89)70008-6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Smith, Dr Molly, Dr Craig Fowler, Dr Indraneel Bhattacharyya, Dr Rekha Reddy y Dr Douglas Damm. "AMELOBLASTIC fiBRO-ODONTOMA: A DISTINCT ENTITY". Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 128, n.º 1 (julio de 2019): e89. http://dx.doi.org/10.1016/j.oooo.2019.02.227.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Dhondt, E., L. Oudenhoven, S. Khan, H. M. Kroon, P. C. Hogendoorn(•), A. Nieborg, J. L. Bloem y A. De Schepper. "Nora’s lesion, a distinct radiological entity?" Skeletal Radiology 35, n.º 7 (7 de abril de 2006): 497–502. http://dx.doi.org/10.1007/s00256-005-0041-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Hyser, Craig L., John T. Kissel, John R. Warmolts y Jerry R. Mendell. "Scapuloperoneal neuropathy: A distinct clinicopathologic entity". Journal of the Neurological Sciences 87, n.º 1 (octubre de 1988): 91–102. http://dx.doi.org/10.1016/0022-510x(88)90057-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

Mori, Makoto, Robert W. Elder y Wendy M. Book. "Adult Fontan failure — Distinct disease entity". International Journal of Cardiology 177, n.º 2 (diciembre de 2014): 650. http://dx.doi.org/10.1016/j.ijcard.2014.09.177.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Krutchkoff, David J. y Ellen Eisenberg. "Lichenoid dysplasia: A distinct histopathologic entity". Oral Surgery, Oral Medicine, Oral Pathology 60, n.º 3 (septiembre de 1985): 308–15. http://dx.doi.org/10.1016/0030-4220(85)90315-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

Bitton, Rachelle N. y Craig Wexler. "Free triiodothyronine toxicosis: A distinct entity". American Journal of Medicine 88, n.º 5 (mayo de 1990): 531–33. http://dx.doi.org/10.1016/0002-9343(90)90435-g.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Sakata, Shigeki y Toru Ogawa. "Free T3 toxicosis: A distinct entity?" American Journal of Medicine 91, n.º 1 (julio de 1991): 100. http://dx.doi.org/10.1016/0002-9343(91)90083-a.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Behranwala, K. A. y J. M. Thomas. "‘Aggressive’ angiomyxoma: a distinct clinical entity". European Journal of Surgical Oncology (EJSO) 29, n.º 7 (septiembre de 2003): 559–63. http://dx.doi.org/10.1016/s0748-7983(03)00104-5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

Van Borsel, John, Sandie Van Der Made y Patrick Santens. "Thalamic stuttering: A distinct clinical entity?" Brain and Language 85, n.º 2 (mayo de 2003): 185–89. http://dx.doi.org/10.1016/s0093-934x(03)00061-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Weatherald, Jason, Peter Dorfmüller, Frédéric Perros, Maria-Rosa Ghigna, Barbara Girerd, Marc Humbert y David Montani. "Pulmonary capillary haemangiomatosis: a distinct entity?" European Respiratory Review 29, n.º 156 (27 de mayo de 2020): 190168. http://dx.doi.org/10.1183/16000617.0168-2019.

Texto completo
Resumen
Pulmonary capillary haemangiomatosis (PCH) is a rare and incompletely understood histopathological finding characterised by abnormal capillary proliferation within the alveolar interstitium, which has long been noted to share many overlapping features with pulmonary veno-occlusive disease (PVOD). But are PCH and PVOD distinct entities that occur in isolation, or are they closely intertwined manifestations along a spectrum of the same disease? The classic clinical features of both PCH and PVOD include signs and symptoms related to pulmonary hypertension, hypoxaemia, markedly impaired diffusion capacity of the lung and abnormal chest imaging with ground glass opacities, septal lines and lymphadenopathy. In recent years, increasing evidence suggests that the clinical presentation, histopathological features, genetic substrate and pathobiological mechanisms of PCH and PVOD are overlapping and usually indistinguishable. The discovery of biallelic mutations in the eukaryotic translation initiation factor 2 α kinase 4 (EIF2AK4) gene in heritable PCH and PVOD greatly advanced our understanding of the overlapping nature of these conditions. Furthermore, recognition of PCH and PVOD-like changes in other pulmonary vascular diseases and in conditions that cause chronic pulmonary venous hyper-perfusion or hypertension suggests that PCH/PVOD may develop as a reactive process to various insults or injuries to the pulmonary vasculature, rather than being primary angiogenic disorders.
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Steensma, David P., Curtis A. Hanson, Louis Letendre y Ayalew Tefferi. "Myelodysplasia with fibrosis: a distinct entity?" Leukemia Research 25, n.º 10 (octubre de 2001): 829–38. http://dx.doi.org/10.1016/s0145-2126(01)00055-8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Durrani, Khayyam y C. Stephen Foster. "Psoriatic uveitis: A distinct clinical entity?" American Journal of Ophthalmology 139, n.º 1 (enero de 2005): 106–11. http://dx.doi.org/10.1016/j.ajo.2004.08.053.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Mackworth-Young, Charles. "Primary antiphospholipid syndrome: A distinct entity?" Autoimmunity Reviews 5, n.º 1 (enero de 2006): 70–75. http://dx.doi.org/10.1016/j.autrev.2005.08.001.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Cohen, Pierre Alain, G. Kalifa, Veronica Donoghue, Catherine Adamsbaum, Faddy Haddad y Jean Dubousset. "Ischio-vertebral dysplasia: a distinct entity". Pediatric Radiology 29, n.º 2 (29 de enero de 1999): 131–34. http://dx.doi.org/10.1007/s002470050556.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Shin, Jung-Ha, Tae-Eun Kim, Kyo-Young Lee, Sang-In Shim y Yeong-Jin Choi. "C1q Nephropathy: A Distinct Pathologic Entity". Korean Journal of Pathology 43, n.º 4 (2009): 335. http://dx.doi.org/10.4132/koreanjpathol.2009.43.4.335.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Kumar, Bhushan y Davinder Parsad. "Is ‘Nodular Tuberculid’ A Distinct Entity?" Pediatric Dermatology 18, n.º 2 (marzo de 2001): 165–66. http://dx.doi.org/10.1046/j.1525-1470.2001.01894-3.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Kokal, William A., L. Robert Hill, David Porudominsky, J. David Beatty, M. Margaret Kemeny, Daniel U. Riihimaki y Ose J. Terz. "Inflammatory breast carcinoma: A distinct entity?" Journal of Surgical Oncology 30, n.º 3 (19 de julio de 2006): 152–55. http://dx.doi.org/10.1002/jso.2930300306.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Roach, E. S. "Is Neuromyelitis Optica a Distinct Entity?" Archives of Neurology 64, n.º 6 (1 de junio de 2007): 906. http://dx.doi.org/10.1001/archneur.64.6.906.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Gulia, Joyti, Shambu Aryal, Haval Saadlla y Andrew F. Shorr. "Healthcare-associated candidemia-A distinct entity?" Journal of Hospital Medicine 5, n.º 5 (9 de junio de 2010): 298–301. http://dx.doi.org/10.1002/jhm.652.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía